Drugs to be subjected to total labeling in Russian pharmaceutical market

Drugs will be the subject for total labeling in the Russian pharmaceutical market according to a recent draft law, which was submitted for the consideration of the national Parliament (State Duma) by the Russian national government, reports The Pharma Letter’s local correspondent.

According to a spokesman of Russia’s Prime Minister Dmitry Medvedev, the new initiative is very important, as its implementation will allow the government to monitor the movement of drugs from producers to consumers.

In addition, the new system will allow the detection of falsified, counterfeit and poor-quality drugs and withdraw them from the Russian market.